25/03/2026
💡 Recommended: A recent study published in Germs explores real-world experiences with a modern regimen!
🏅 / / (DOR/3TC/TDF) Treatment in People Living with : A Single-Center Real-World Experience from Belgrade, Serbia
🌐Link: https://brnw.ch/21x12Ma
📌In the era of modern (ART), focus has expanded beyond viral suppression to the broader issues of overall health, quality of life, and comorbidity management for people living with HIV. The burden of non-communicable , including (CVD), (CKD), and , is becoming more pronounced as this population ages. Thus, modern ART aims not only to prevent disease progression but also to ensure long-term safety, minimize treatment-related toxicities, and reduce cardiovascular and metabolic risks.
👤Authors: Marko Markovic, Jovan Ranin, Aleksa Despotovic, Ivan Rajkovic, Jovana Ranin, Milan Tanasijevic, Nikola Mitrovic, Natasa Nikolic, Ivana Milosevic and Ivana Gmizic
👉Read full paper: https://brnw.ch/21x12Ma
Introduction: Doravirine/lamivudine/tenofovir disoproxil fumarate (DOR/3TC/TDF) is recommended for both ART initiation and switch in virologically suppressed patients. We report early real-world outcomes after DOR/3TC/TDF introduction in Belgrade, Serbia. Methods: We conducted a single-center retros...